mk 0663 has been researched along with pantoprazole in 2 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (pantoprazole) | Trials (pantoprazole) | Recent Studies (post-2010) (pantoprazole) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 1,467 | 476 | 579 |
| Protein | Taxonomy | mk 0663 (IC50) | pantoprazole (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 1.5 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.75 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Soares, J | 1 |
2 other study(ies) available for mk 0663 and pantoprazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Low-dose aspirin reduces gastro-protective properties of COX-2 selective inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Cyclooxygenase 2 Inhibitors; Drug Interactions; Duodenal Ulcer; Etoricoxib; Female; Humans; Middle Aged; Pantoprazole; Peptic Ulcer Hemorrhage; Pyridines; Sulfones | 2009 |